ACIST® Medical Systems, a Bracco Group company, develops advanced contrast injection technologies that help simplify the complexities of the cardiac cath lab, hybrid operating room and radiology suite.

BARD markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities.

BARD pioneered the development of single-patient-use medical products for hospital procedures; today BARD is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall costs.

BARD,s core values of Quality, Integrity, Service, and Innovation represent our reality and our aspirations. These four values prepare us for the challenges ahead and guide our everyday activities and align us to our mission. They are central to how we behave and want to be viewed by our fellow co-workers, customers, shareholders and communities.

B. Braun supplies the global healthcare market with products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment and surgery, as well as services for hospitals, general practitioners and the homecare sector.

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available of congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.

Claret Medical, Inc. is a cardiovascular medical device company developing novel cerebral vascular protection systems for Transcatheter Aortic Valve Implantation (TAVI), other endovascular procedures and surgical aortic valve replacement. Today, the TAVI procedure has an inherent risk of stroke but does not utilize any form of cerebral vascular protection as standard of care. Advanced embolic filter devices and techniques developed by Claret Medical are designed to capture and remove embolic material released during these procedures and provide a more predictable and positive outcome for physicians and their patients.
ImThera Medical has developed a novel, fully implanted neurostimulation device for the treatment of Obstructive Sleep Apnea (OSA). Imthera’s THN Sleep Therapy uses neurostimulation techniques and incorporates proprietary technology to deliver muscle tone to key tongue muscles during sleep, hence opening the upper airway and substantially reducing or eliminating OSA events.

Our mission is to help patients live longer and enjoy better lives while substantially reducing health care costs related to serious complications associated with Obstructive Sleep Apnea.
ImThera Medical was formed in 2008 and is headquartered in San Diego, CA (USA).

Perouse Medical is a benchmark company in the international medical devices market.

Its offer, distinguished by the ability to combine technological performance, service, quality and product reliability extends into four key fields: cardiovascular, oncology, interventional imaging and Business to Business.

The multi-disciplinary research and development teams and a unique technology portfolio enable PEROUSE MEDICAL to make all its technological expertise available to the practitioners and to the medical industry.

All the products developed, manufactured and marketed by PEROUSE MEDICAL meet international regulatory requirements.

ReCor Medical has developed a unique therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The PARADISE® technology (Percutaneous Renal Denervation System) includes a 6 French catheter with a cylindrical transducer that emits ultrasound energy circumferentially, allowing for a more efficient renal denervation procedure.

Vascular Solutions is a medical device company committed to providing superior clinical solutions for diagnostic and interventional vascular procedures. Founded in 1997, Vascular Solutions is a publicly held company that trades on the NASDAQ National Market under the symbol VASC.

Vascular Innovations Co. Ltd is a medical device company primarily involved in the manufacture of occlusion devices. It also distributes devices from other manufactures relating to the coronary system.

The corporate office and manufacturing facility is located in Nonthaburi, Thailand. The company manufactures and sells directly to the Thailand market. Its devices are made available in the international market through a wide network of distributors. As part of the expansion process it is continously negotiating with international distributors.


New technology coming soon:

InterVene, Inc. is developing the first non-implant-able, catheter-based therapy to treat the valvular pathophysiology of chronic venous.